1. Home
  2. NPCE vs TECX Comparison

NPCE vs TECX Comparison

Compare NPCE & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.09

Market Cap

536.6M

Sector

Health Care

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$32.08

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
TECX
Founded
1997
2019
Country
United States
United States
Employees
N/A
60
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.6M
549.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NPCE
TECX
Price
$16.09
$32.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$18.33
$75.20
AVG Volume (30 Days)
172.6K
184.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$99,986,000.00
N/A
Revenue This Year
$0.90
N/A
Revenue Next Year
$24.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$14.39
52 Week High
$19.60
$39.53

Technical Indicators

Market Signals
Indicator
NPCE
TECX
Relative Strength Index (RSI) 47.96 48.88
Support Level $15.42 $27.31
Resistance Level $17.49 $35.99
Average True Range (ATR) 0.88 2.76
MACD -0.06 -0.47
Stochastic Oscillator 22.09 21.07

Price Performance

Historical Comparison
NPCE
TECX

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: